Klotho Neurosciences to Broaden Development Programs Beyond Neurology
Klotho Neurosciences, Inc. has announced plans to expand beyond neurology by exploring acquisitions of complementary technologies that support brain health, organ function, and longevity, building on its proprietary anti-ageing Klotho platform.
Dr. Joseph Sinkule | 25/07/2025 | By Mrinmoy Dey
Klotho Neurosciences Parteners with AAVnerGene to Manufacture Gene Therapy Assets
Klotho Neurosciences has partnered with AAVnerGene to leverage its next-generation AAV manufacturing and targeted delivery platforms, aiming to accelerate the clinical development of gene therapies for neurological and age-related diseases.
Dr. Joseph Sinkule | 23/07/2025 | By Mrinmoy Dey
Klotho Neurosciences Advances Gene Therapy Manufacturing for ALS Treatment
Klotho Neurosciences has announced the initiation of manufacturing and process development for KLTO-202, its investigational gene therapy targeting ALS, with plans to begin clinical trials by Q3 next year.
Dr. Joseph Sinkule | 02/07/2025 | By Mrinmoy Dey | 174
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy